Quantcast
Last updated on April 16, 2014 at 17:34 EDT

CareFusion Receives Federal Data Encryption Certification for Alaris® Infusion System

January 17, 2012

SAN DIEGO, Jan. 17, 2012 /PRNewswire/ — CareFusion today announced its Alaris System wireless security solution is the first and only infusion system to receive a new data encryption certification now required for infusion devices operating on U.S. Department of Veterans Affairs hospital networks.

(Logo: http://photos.prnewswire.com/prnh/20100706/CAREFUSIONLOGO)

The certification, known as Federal Information Processing Standard (FIPS) 140-2, certifies that the Alaris System is compliant with stringent wireless encryption and physical security requirements set by the National Institute of Standards and Technology (NIST).

The NIST FIPS program defines various levels of physical and data encryption security that devices must meet in order to operate on Federal wireless networks. The FIPS 140-2 standard is designed to protect sensitive but unclassified information, such as electronic health records. CareFusion’s Alaris® Systems Manager facilitates wireless communications between the Alaris infusion pump system and a hospital’s wireless network to provide an enterprise-grade, secure deployment architecture.

“We’ve been helping the VA network of hospitals deliver quality care for many years,” said JC Kyrillos, senior vice president and general manager of Infusion Systems at CareFusion. “This federal certification underscores CareFusion’s commitment to advanced technology that is designed to protect patient safety and confidentiality. In the event this wireless security requirement extends to other Federal care providers, we are well positioned and ready to support provider needs.”

The Alaris System is a comprehensive IV medication delivery system and the only such technology now compliant with FIPS 140-2. The Alaris System is a modular infusion platform that integrates a single, point-of-care unit featuring Guardrails® Suite MX safety software with large volume pump, Patient Controlled Analgesia, respiratory monitoring (SpO2 and EtCO2) syringe and barcoding capabilities across all infusion modalities. The Alaris System combined with the Alaris Systems Manager helps improve safety and reduce costs as part of an integrated system that helps streamline workflow and wirelessly manages and transfers infusion data.

About CareFusion
CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops market-leading technologies including Alaris® infusion pumps, Pyxis® automated dispensing and patient identification systems, AVEA®, AirLife(TM) and LTV® series ventilation and respiratory products, ChloraPrep® skin prep products, MedMined(TM) services for data mining surveillance, Nicolet(TM) neurological monitoring and diagnostic products, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs more than 14,000 people across its global operations. More information may be found at www.carefusion.com.

SOURCE CareFusion


Source: PR Newswire